Skip to main content
Top
Published in: Urolithiasis 5/2016

01-10-2016 | Original Paper

Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers

Authors: Joshua M. Stern, Saman Moazami, Yunping Qiu, Irwin Kurland, Zigui Chen, Ilir Agalliu, Robert Burk, Kelvin P. Davies

Published in: Urolithiasis | Issue 5/2016

Login to get access

Abstract

The trillions of microbes that colonize our adult intestine are referred to as the gut microbiome (GMB). Functionally it behaves as a metabolic organ that communicates with, and complements, our own human metabolic apparatus. While the relationship between the GMB and kidney stone disease (KSD) has not been investigated, dysbiosis of the GMB has been associated with diabetes, obesity and cardiovascular disease. In this pilot study we sought to identify unique changes in the GMB of kidney stone patients compared to patients without KSD. With an IRB-approved protocol we enrolled 29 patients into our pilot study. 23 patients were kidney stone formers and six were non-stone forming controls. Specimens were collected after a 6h fast and were flash frozen in dry ice and then stored at −80 °C. Microbiome: determination of bacterial abundance was by analysis of 16 s rRNA marker gene sequences using next generation sequencing. Sequencing of the GMB identified 178 bacterial genera. The five most abundant enterotypes within each group made up to greater than 50 % of the bacterial abundance identified. Bacteroides was 3.4 times more abundant in the KSD group as compared to control (34.9 vs 10.2 %; p = 0.001). Prevotella was 2.8 times more abundant in the control group as compared to the KSD group (34.7 vs 12.3 %; p = 0.005). In a multivariate analysis including age, gender, BMI, and DM, kidney stone disease remained an increased risk for high prevalence for Bacteroides (OR = 3.26, p = 0.033), whereas there was an inverse association with Prevotella (OR = 0.37, p = 0.043). There were no statistically significant differences in bacterial abundance levels for Bacteroides or Prevotella when comparing patients with and without DM, obesity (BMI >30), HTN or HLD. 11 kidney stone patients completed 24 h urine analysis at the time of this writing. Looking at the bacterial genuses with at least 4 % abundance in the kidney stone group, Eubacterium was inversely correlated with oxalate levels (r = −0.60, p < 0.06) and Escherichia trended to an inverse correlation with citrate (r = −0.56, p < 0.08). We also compared bacterial abundance between uric acid (UA) stone formers (n = 5) and non UA stone formers (n = 18) and found no significant difference between them. We identified two genus of bacteria in the GMB that had significant association with KSD. Interestingly, components of the 24-h urine appear to be correlated to bacterial abundance. These preliminary studies for the first time associate differences in the GMB with kidney stone formation. Further studies are warranted to evaluate the potential causative role of preexisting dysbiosis in kidney stone disease.
Literature
1.
go back to reference Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic diseases in America P (2012) Prevalence of kidney stones in the United States. Eur Urol 62:160–165CrossRefPubMedPubMedCentral Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic diseases in America P (2012) Prevalence of kidney stones in the United States. Eur Urol 62:160–165CrossRefPubMedPubMedCentral
2.
go back to reference Antonelli JA, Maalouf NM, Pearle MS, Lotan Y (2014) Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol 66:724–729CrossRefPubMedPubMedCentral Antonelli JA, Maalouf NM, Pearle MS, Lotan Y (2014) Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol 66:724–729CrossRefPubMedPubMedCentral
3.
go back to reference Lange JN, Mufarrij PW, Wood KD, Holmes RP, Assimos DG (2012) The association of cardiovascular disease and metabolic syndrome with nephrolithiasis. Curr Opin Urol 22:154–159CrossRefPubMed Lange JN, Mufarrij PW, Wood KD, Holmes RP, Assimos DG (2012) The association of cardiovascular disease and metabolic syndrome with nephrolithiasis. Curr Opin Urol 22:154–159CrossRefPubMed
4.
5.
go back to reference Domingos F, Serra A (2011) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26:864–868CrossRefPubMed Domingos F, Serra A (2011) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26:864–868CrossRefPubMed
6.
go back to reference Ferraro PM, Taylor EN, Eisner BH et al (2013) History of kidney stones and the risk of coronary heart disease. JAMA J Am Med Assoc 24(310):408–415CrossRef Ferraro PM, Taylor EN, Eisner BH et al (2013) History of kidney stones and the risk of coronary heart disease. JAMA J Am Med Assoc 24(310):408–415CrossRef
7.
go back to reference Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 15:3225–3232CrossRefPubMed Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 15:3225–3232CrossRefPubMed
8.
go back to reference Tracy CR, Best S, Bagrodia A et al (2014) Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol 192:137–141CrossRefPubMed Tracy CR, Best S, Bagrodia A et al (2014) Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol 192:137–141CrossRefPubMed
10.
go back to reference Borghi L, Schianchi T, Meschi T et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 10(346):77–84CrossRef Borghi L, Schianchi T, Meschi T et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 10(346):77–84CrossRef
11.
go back to reference Suez J, Korem T, Zeevi D et al (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 9(514):181–186 Suez J, Korem T, Zeevi D et al (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 9(514):181–186
12.
go back to reference Everard A, Cani PD (2013) Diabetes, obesity and gut microbiota. Best Pract Res Cl Ga. 27:73–83CrossRef Everard A, Cani PD (2013) Diabetes, obesity and gut microbiota. Best Pract Res Cl Ga. 27:73–83CrossRef
13.
go back to reference Andrade-Oliveira V, Amano MT, Correa-Costa M, et al (2015) Gut bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol Andrade-Oliveira V, Amano MT, Correa-Costa M, et al (2015) Gut bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol
14.
go back to reference Wang Z, Klipfell E, Bennett BJ et al (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 7(472):57–63CrossRef Wang Z, Klipfell E, Bennett BJ et al (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 7(472):57–63CrossRef
15.
go back to reference Heimann E, Nyman M, Degerman E (2015) Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes. Adipocyte 4:81–88CrossRefPubMed Heimann E, Nyman M, Degerman E (2015) Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes. Adipocyte 4:81–88CrossRefPubMed
16.
go back to reference Wang Y, Qian PY (2009) Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS One 4:e7401CrossRefPubMedPubMedCentral Wang Y, Qian PY (2009) Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS One 4:e7401CrossRefPubMedPubMedCentral
17.
go back to reference Hamady M, Walker JJ, Harris JK, Gold NJ, Knight R (2008) Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods 5:235–237CrossRefPubMedPubMedCentral Hamady M, Walker JJ, Harris JK, Gold NJ, Knight R (2008) Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods 5:235–237CrossRefPubMedPubMedCentral
18.
go back to reference Smith BC, McAndrew T, Chen Z et al (2012) The cervical microbiome over 7 years and a comparison of methodologies for its characterization. PLoS One 7:e40425CrossRefPubMedPubMedCentral Smith BC, McAndrew T, Chen Z et al (2012) The cervical microbiome over 7 years and a comparison of methodologies for its characterization. PLoS One 7:e40425CrossRefPubMedPubMedCentral
19.
20.
go back to reference Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 1(26):2460–2461CrossRef Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 1(26):2460–2461CrossRef
21.
go back to reference Matsen FA, Kodner RB, Armbrust EV (2010) pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree. BMC Bioinform 11:538CrossRef Matsen FA, Kodner RB, Armbrust EV (2010) pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree. BMC Bioinform 11:538CrossRef
22.
go back to reference Lozupone C, Knight R (2005) UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microb 71:8228–8235CrossRef Lozupone C, Knight R (2005) UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microb 71:8228–8235CrossRef
23.
go back to reference Karlsson FH, Tremaroli V, Nookaew I et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 6(498):99–103CrossRef Karlsson FH, Tremaroli V, Nookaew I et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 6(498):99–103CrossRef
24.
go back to reference Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 4(490):55–60CrossRef Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 4(490):55–60CrossRef
25.
go back to reference Vrieze A, Van Nood E, Holleman F et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143(913–6):e7PubMed Vrieze A, Van Nood E, Holleman F et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143(913–6):e7PubMed
26.
go back to reference Vitetta L, Linnane AW, Gobe GC (2013) From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling. Toxins 5:2042–2057CrossRefPubMedPubMedCentral Vitetta L, Linnane AW, Gobe GC (2013) From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling. Toxins 5:2042–2057CrossRefPubMedPubMedCentral
27.
go back to reference Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urology 189:803–811CrossRef Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urology 189:803–811CrossRef
28.
go back to reference Puddu A, Sanguineti R, Montecucco F, Viviani GL (2014) Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediat Inflamm 2014:162021 Puddu A, Sanguineti R, Montecucco F, Viviani GL (2014) Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediat Inflamm 2014:162021
29.
go back to reference De Filippo C, Cavalieri D, Di Paola M et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci 17(107):14691–14696CrossRef De Filippo C, Cavalieri D, Di Paola M et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci 17(107):14691–14696CrossRef
30.
go back to reference David LA, Maurice CF, Carmody RN et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 23(505):559–563 David LA, Maurice CF, Carmody RN et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 23(505):559–563
31.
go back to reference Wu GD, Chen J, Hoffmann C et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 7(334):105–108CrossRef Wu GD, Chen J, Hoffmann C et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 7(334):105–108CrossRef
32.
go back to reference Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci 108(Suppl 1):4554–4561CrossRefPubMed Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci 108(Suppl 1):4554–4561CrossRefPubMed
Metadata
Title
Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers
Authors
Joshua M. Stern
Saman Moazami
Yunping Qiu
Irwin Kurland
Zigui Chen
Ilir Agalliu
Robert Burk
Kelvin P. Davies
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 5/2016
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-016-0882-9

Other articles of this Issue 5/2016

Urolithiasis 5/2016 Go to the issue